MILRINONE LACTATE Drug Patent Profile

« Back to Dashboard

Which patents cover Milrinone Lactate, and when can generic versions of Milrinone Lactate launch?

Milrinone Lactate is a drug marketed by Baxter Hlthcare Corp, Caplin, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Intl Medicated, Meitheal, Mylan Institutional, Shandong, Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, and Gland. and is included in twenty-six NDAs.

The generic ingredient in MILRINONE LACTATE is milrinone lactate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Milrinone Lactate

A generic version of MILRINONE LACTATE was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Summary for MILRINONE LACTATE

US Patents:	0
Applicants:	16
NDAs:	26
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	28
Clinical Trials:	5
Patent Applications:	291
Drug Prices:	Drug price information for MILRINONE LACTATE
DailyMed Link:	MILRINONE LACTATE at DailyMed

See drug prices for MILRINONE LACTATE

Recent Clinical Trials for MILRINONE LACTATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shanghai Children's Medical Center	Phase 3
Ottawa Heart Institute Research Corporation	Phase 4
Bedford Pharmaceuticals	N/A

See all MILRINONE LACTATE clinical trials

Pharmacology for MILRINONE LACTATE

Drug Class	Phosphodiesterase 3 Inhibitor
Mechanism of Action	Phosphodiesterase 3 Inhibitors

Medical Subject Heading (MeSH) Categories for MILRINONE LACTATE

Cardiotonic Agents

Phosphodiesterase 3 Inhibitors

Platelet Aggregation Inhibitors

Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for MILRINONE LACTATE

C01CE	Phosphodiesterase inhibitors
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for MILRINONE LACTATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	077151-001	Jul 20, 2005		DISCN	No	No
Hikma	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	078113-001	May 21, 2008	AP	RX	No	No
Hikma Farmaceutica	MILRINONE LACTATE IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	090038-001	Jan 21, 2010	AP	RX	No	No
Hikma	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	078113-002	May 21, 2008	AP	RX	No	No
Baxter Hlthcare Corp	MILRINONE LACTATE	milrinone lactate	INJECTABLE;INJECTION	076427-001	Sep 21, 2004		DISCN	No	No
Eugia Pharma	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	209666-001	Sep 3, 2020	AP	RX	No	No
Baxter Hlthcare	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075834-002	May 28, 2002	AP	RX	No	Yes